Literature DB >> 24467558

Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.

Ronald Klein1, Stacy M Meuer, Chelsea E Myers, Gabriëlle H S Buitendijk, Elena Rochtchina, Farzana Choudhury, Paulus T V M de Jong, Roberta McKean-Cowdin, Sudha K Iyengar, Xiaoyi Gao, Kristine E Lee, Johannes R Vingerling, Paul Mitchell, Caroline C W Klaver, Jie Jin Wang, Barbara E K Klein.   

Abstract

PURPOSE: To describe methods to harmonize the classification of age-related macular degeneration (AMD) phenotypes across four population-based cohort studies: the Beaver Dam Eye Study (BDES), the Blue Mountains Eye Study (BMES), the Los Angeles Latino Eye Study (LALES), and the Rotterdam Study (RS).
METHODS: AMD grading protocols, definitions of categories, and grading forms from each study were compared to determine whether there were systematic differences in AMD severity definitions and lesion categorization among the three grading centers. Each center graded the same set of 60 images using their respective systems to determine presence and severity of AMD lesions. A common 5-step AMD severity scale and definitions of lesion measurement cutpoints and early and late AMD were developed from this exercise.
RESULTS: Applying this severity scale changed the age-sex adjusted prevalence of early AMD from 18.7% to 20.3% in BDES, from 4.7% to 14.4% in BMES, from 14.1% to 15.8% in LALES, and from 7.5% to 17.1% in RS. Age-sex adjusted prevalences of late AMD remained unchanged. Comparison of each center's grades of the 60 images converted to the consortium scale showed that exact agreement of AMD severity among centers varied from 61.0-81.4%, and one-step agreement varied from 84.7-98.3%.
CONCLUSION: Harmonization of AMD classification reduced categorical differences in phenotypic definitions across the studies, resulted in a new 5-step AMD severity scale, and enhanced similarity of AMD prevalence among the four cohorts. Despite harmonization it may still be difficult to remove systematic differences in grading, if present.

Entities:  

Mesh:

Year:  2014        PMID: 24467558      PMCID: PMC4029416          DOI: 10.3109/09286586.2013.867512

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  40 in total

1.  Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Michael D Knudtson; Stacy M Meuer; Maria Swift; Ronald E Gangnon
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

2.  Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Kristine E Lee; Karen J Cruickshanks; Ronald E Gangnon
Journal:  Am J Ophthalmol       Date:  2006-10       Impact factor: 5.258

3.  Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.

Authors:  Jie Jin Wang; Elena Rochtchina; Anne J Lee; Ee-Munn Chia; Wayne Smith; Robert G Cumming; Paul Mitchell
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

4.  Changes in visual acuity in a population. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; K E Lee
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

5.  The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17.

Authors:  Matthew D Davis; Ronald E Gangnon; Li-Yin Lee; Larry D Hubbard; Barbara E K Klein; Ronald Klein; Frederick L Ferris; Susan B Bressler; Roy C Milton
Journal:  Arch Ophthalmol       Date:  2005-11

Review 6.  Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss
Journal:  Am J Epidemiol       Date:  1998-01-15       Impact factor: 4.897

Review 7.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

8.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S C Jensen; S M Meuer
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

9.  The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions.

Authors:  Marilyn C Cornelis; Arpana Agrawal; John W Cole; Nadia N Hansel; Kathleen C Barnes; Terri H Beaty; Siiri N Bennett; Laura J Bierut; Eric Boerwinkle; Kimberly F Doheny; Bjarke Feenstra; Eleanor Feingold; Myriam Fornage; Christopher A Haiman; Emily L Harris; M Geoffrey Hayes; John A Heit; Frank B Hu; Jae H Kang; Cathy C Laurie; Hua Ling; Teri A Manolio; Mary L Marazita; Rasika A Mathias; Daniel B Mirel; Justin Paschall; Louis R Pasquale; Elizabeth W Pugh; John P Rice; Jenna Udren; Rob M van Dam; Xiaojing Wang; Janey L Wiggs; Kayleen Williams; Kai Yu
Journal:  Genet Epidemiol       Date:  2010-05       Impact factor: 2.135

Review 10.  An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

Authors:  A C Bird; N M Bressler; S B Bressler; I H Chisholm; G Coscas; M D Davis; P T de Jong; C C Klaver; B E Klein; R Klein
Journal:  Surv Ophthalmol       Date:  1995 Mar-Apr       Impact factor: 6.048

View more
  34 in total

Review 1.  The prevalence of age-related eye diseases and visual impairment in aging: current estimates.

Authors:  Ronald Klein; Barbara E K Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

2.  Oxidized Low-density Lipoprotein and the Incidence of Age-related Macular Degeneration.

Authors:  Ronald Klein; Kristine E Lee; Michael Y Tsai; Karen J Cruickshanks; Ronald E Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2018-12-17       Impact factor: 12.079

3.  Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Chelsea E Myers; Barbara E K Klein; Ronald Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Ronald Klein
Journal:  Ophthalmology       Date:  2014-06-20       Impact factor: 12.079

4.  Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium.

Authors:  Gabriëlle H S Buitendijk; Elena Rochtchina; Chelsea Myers; Cornelia M van Duijn; Kristine E Lee; Barbara E K Klein; Stacy M Meuer; Paulus T V M de Jong; Elizabeth G Holliday; Ava G Tan; André G Uitterlinden; Theru S Sivakumaran; John Attia; Albert Hofman; Paul Mitchell; Johannes R Vingerling; Sudha K Iyengar; A Cecile J W Janssens; Jie Jin Wang; Ronald Klein; Caroline C W Klaver
Journal:  Ophthalmology       Date:  2013-10-10       Impact factor: 12.079

Review 5.  [Epidemiology of age-related macular degeneration].

Authors:  C Brandl; K J Stark; M Wintergerst; M Heinemann; I M Heid; R P Finger
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

6.  The prevalence and risk factors for age-related macular degeneration in rural-urban India, Sankara Nethralaya Rural-Urban Age-related Macular degeneration study, Report No. 1.

Authors:  R Raman; S S Pal; S Ganesan; L Gella; K Vaitheeswaran; T Sharma
Journal:  Eye (Lond)       Date:  2016-02-26       Impact factor: 3.775

7.  A Novel Method for Classifying Hearing Impairment in Epidemiological Studies of Aging: The Wisconsin Age-Related Hearing Impairment Classification Scale.

Authors:  Karen J Cruickshanks; David M Nondahl; Mary E Fischer; Carla R Schubert; Ted S Tweed
Journal:  Am J Audiol       Date:  2020-02-03       Impact factor: 1.493

8.  Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Barbara E K Klein
Journal:  Ophthalmology       Date:  2014-04-29       Impact factor: 12.079

9.  Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report.

Authors:  Nichole Joachim; Johanna Maria Colijn; Annette Kifley; Kristine E Lee; Gabriëlle H S Buitendijk; Barbara E K Klein; Chelsea E Myers; Stacy M Meuer; Ava G Tan; Elizabeth G Holliday; John Attia; Gerald Liew; Sudha K Iyengar; Paulus T V M de Jong; Albert Hofman; Johannes R Vingerling; Paul Mitchell; Caroline C W Klaver; Ronald Klein; Jie Jin Wang
Journal:  Br J Ophthalmol       Date:  2017-01-20       Impact factor: 4.638

10.  Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Karen J Cruickshanks; Ronald E Gangnon; Lorraine G Danforth; Theru A Sivakumaran; Sudha K Iyengar; Michael Y Tsai; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.